Testing for recent use, within just a few hours, provides a true solution—a “Win-Win” for all involved.


breathalyzers to measure recent marijuana use. Employees are also the beneficiaries, as they will be able to legally and responsibly use marijuana outside of work hours if they choose, without having to worry about a positive test being triggered by legal use a week earlier. In addition, legislators are beginning


to understand that new laws that prohibit certain types of drug testing create unintended consequences. Te best new laws that protect legal rights and promote safety for employees and customers are laws that allow the use of the latest technology and promote the evolution of employee testing without eliminating it. With the use of marijuana breathalyzers, onsite pre-access and post-accident drug testing will become the new normal— allowing employers to ignore lifestyle choices and focus on marijuana and other drug use during work hours to determine whether an employee should access a site before the accident occurs. Tis approach to drug testing in combination with recovery-supportive work policies will help to ensure a competitive workforce for the new decade. ❚


Reference 1


Substance Abuse and Mental Health Services Administration. Behavioral Health Barometer: United States, 2015. HHS Publication No. SMA–16–Baro–2015. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2015.


2


http://home.trafficresourcecenter.org/~/media/Microsites/ Files/traffic-safety/NHTSA-Drugs_Human_Performance.ashx.


3 4 http://clinchem.aaccjnls.org/content/65/9/1171.


http://home.trafficresourcecenter.org/~/media/ Microsites/Files/traffic-safety/NHTSA-Drugs_Human_ Performance.ashx.


18 datia focus


Jenny Lynn is the Co-Founder and Chief Marketing Officer of Hound Labs, Inc., creators of the world’s first dual marijuana and alcohol breathalyzer. Jenny's current


responsibilities at Hound Labs include overseeing corporate marketing, media relations, communications, and product marketing—all of which have provided opportunities to speak with countless employers over the last seven years about drug testing in the new era of marijuana legalization. In these conversations, employers have shared their concerns about the issues they are facing as a result of legalization and their frustration at the inability to maintain safe and fair drug testing policies. An experienced marketing executive


with an extensive background in launching new companies and products across a wide range of business sectors, Jenny has experience in the finance, consumer products, education, and tech industries. Before joining Hound Labs, Jenny was the Global Head of Marketing for Camberview Partners, LLC—experts from the investor community to help public companies understand, engage, and succeed with their investors in complex and contested shareholder matters.


A former White House Fellow who helped brand initiatives for the US Department of Education, Jenny graduated Phi Beta Kappa from Boston College with a BA in philosophy and concentrations in business and social justice and received her MBA from Northwestern’s Kellogg Graduate School of Management. Jenny currently volunteers with area charities. In addition to her role with Hound Labs, Ms. Lynn is a co-founder of the Hound Foundation, a nonprofit established in 2015 to raise awareness about the dangers of driving under the influence of marijuana.


Nina M. French is the SVP of Employer Solutions for Hound Labs, Inc., creators of the world’s first dual marijuana and alcohol breathalyzer. Before joining Hound Labs,


Nina was Managing Partner for the Current Consulting Group (CCG) with over 27 years in the employee screening industry. Nina began her career at the infancy of the


drug screening industry as the operations manager for a start-up company, Employee Health Programs (EHP). EHP was founded by Dr. Donald Ian Macdonald, former Head of the White House Drug Abuse Policy Office (DAPO) and the Administrator of Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA). Nina was an integral part of the growth of EHP from a 13-person company to one of the top two screening firms in the US. Nina’s experience includes product development, program design, vendor management, medical review, client success, marketing, and sales strategy. She is a nationally recognized expert in substance abuse testing and is widely respected throughout the industry as a thought leader. Nina formed CCG in 2014 and developed it into the leading consulting company in drug testing. She provides management consulting and training to drug screening providers, laboratories, device manufacturers, and large employers across the United States. Nina has extensive knowledge of and experience with drug testing statutes, regulations, and case law including chain of custody and alcohol and drug testing protocols.


Nina is a graduate of the Catholic University of America and served as a board member of the Drug and Alcohol Testing Industry Association (DATIA). She is widely published and has been featured by US News and World Report, NBC News, EHS, OHS, SHRM, DATIA, SAPAA, NAPBS, and speaks at over 40 industry events annually.


2020 • Issue 2


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48